Pain Relief Goes Global: IOL Chemicals’ Ibuprofen Wins Coveted China Export Nod

IOL Chemicals & Pharmaceuticals Ltd (IOLCP), India's largest manufacturer of APIs and a world leader in the manufacture of Ibuprofen, today announced that it has received approval from China's National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) to export its Ibuprofen API into China.

 

This regulatory milestone allows IOLCP to increase its international presence and establish itself as a major provider of Ibuprofen, a common pain killer and anti-inflammatory drug. The company, which already has major international accreditations and exports Ibuprofen to more than 40 nations, can now directly address the increasing pharmaceutical requirements of China, one of the globe's largest healthcare markets.

 

With this sanction, IOLCP expands its product portfolio and reinforces its export base further, riding on its established track record of quality and regulatory compliance. The backward-integrated manufacturing facility of the company and its robust capacities enable it to serve domestic as well as international demand for Ibuprofen and other specialty APIs.

 

Source: Business StandardIOL Chemicals & Pharmaceuticals Ltd (IOLCP), India's largest manufacturer of APIs and a world leader in the manufacture of Ibuprofen, today announced that it has received approval from China's National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) to export its Ibuprofen API into China.

 

This regulatory milestone allows IOLCP to increase its international presence and establish itself as a major provider of Ibuprofen, a common pain killer and anti-inflammatory drug. The company, which already has major international accreditations and exports Ibuprofen to more than 40 nations, can now directly address the increasing pharmaceutical requirements of China, one of the globe's largest healthcare markets.

 

With this sanction, IOLCP expands its product portfolio and reinforces its export base further, riding on its established track record of quality and regulatory compliance. The backward-integrated manufacturing facility of the company and its robust capacities enable it to serve domestic as well as international demand for Ibuprofen and other specialty APIs.

 

Source: Business Standard